Skip to Content
You are currently on the new version of our website. Access the old version .

441 Results Found

  • Article
  • Open Access
20 Citations
5,869 Views
25 Pages

Artemisia annua Extract Improves the Cognitive Deficits and Reverses the Pathological Changes of Alzheimer’s Disease via Regulating YAP Signaling

  • Wenshu Zhou,
  • Bingxi Lei,
  • Chao Yang,
  • Marta Silva and ,
  • Xingan Xing,
  • Hua Yu,
  • Jiahong Lu and
  • Wenhua Zheng
  • + 3 authors+ 0 author

Alzheimer’s disease (AD) is a chronic neurodegenerative disease characterized by the occurrence of cognitive deficits. With no effective treatments available, the search for new effective therapies has become a major focus of interest. In the p...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
4 Citations
2,625 Views
12 Pages

Association between Gray and White Matter Lesions and Its Involvement in Clinical Symptoms of Alzheimer’s-Type Dementia

  • Taizen Nakase,
  • Benjamin Thyreau,
  • Yasuko Tatewaki,
  • Naoki Tomita and ,
  • Yumi Takano,
  • Michiho Muranaka and
  • Yasuyuki Taki
  • + 2 authors+ 0 author

12 December 2023

Background: Not only gray matter lesions (GMLs) but also white matter lesions (WMLs) can play important roles in the pathology of Alzheimer’s disease (AD). The progression of cognitive impairment (CI) and behavioral and psychological symptoms o...

(This article belongs to the Topic Applications of Biomedical Technology and Molecular Biological Approach in Brain Diseases)
  • Review
  • Open Access
5 Citations
1,866 Views
13 Pages

10 September 2025

Neurodegenerative diseases such as Alzheimer’s disease (AD), frontotemporal lobar degeneration (FTLD), and α-synucleinopathies—including Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (M...

(This article belongs to the Special Issue Development of PET Radiotracers for Imaging Alpha-Synuclein)
  • Article
  • Open Access
4 Citations
2,715 Views
22 Pages

The development of more effective disease-modifying treatments for Alzheimer’s disease (AD) is compromised by the lack of streamlined measures to detect and monitor the full spectrum of neurodegeneration, including white matter pathology, which...

(This article belongs to the Special Issue The Role of Extracellular Vesicles in Inflammatory Diseases)
  • Article
  • Open Access
1 Citations
1,390 Views
24 Pages

Pharmacokinetic and Pharmacodynamic Evaluation of PZ-2891, an Anti-Alzheimer’s Disease Agonist of PANK2

  • Ying Chen,
  • Huimin Ma,
  • Mengyao Jin,
  • Shize Zhang and ,
  • Shimeng Qu,
  • Guangji Wang and
  • Jiye Aa
  • + 2 authors+ 0 author

9 December 2025

Background/Objectives: Alzheimer’s disease (AD) is a neurodegenerative disorder with a high incidence but limited agents. Herein, PZ-2891 was discovered as a novel anti-AD candidate. Both in vivo and in vitro pharmacodynamic (PD) studies and ph...

(This article belongs to the Section Medicinal Chemistry)
  • Review
  • Open Access
7 Citations
4,100 Views
28 Pages

16 December 2024

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with cognitive dysfunction, memory decline, and behavioral disturbance, and it is pathologically characterized by the accumulation of amyloid plaques and neurofibrillary tangl...

(This article belongs to the Special Issue Chemical Biology in Asia)
  • Review
  • Open Access
6 Citations
3,379 Views
39 Pages

26 August 2025

One hundred and eighteen years have passed since Alzheimer’s disease (AD) was first diagnosed by Alois Alzheimer as a multifactorial and complex neurodegenerative disorder with psychiatric components. It is inaugurated by a cascade of events in...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
4 Citations
2,979 Views
16 Pages

24 June 2022

The amyloid pathology characteristic of Alzheimer’s disease (AD) can be broadly classified as either fibrillary amyloid or diffuse amyloid. Fibrillary amyloid is found in cored-neuritic deposits, fibrillar deposits, and vascular deposits, and b...

  • Article
  • Open Access
12 Citations
3,610 Views
22 Pages

Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function

  • Erin E. Sundermann,
  • Laura M. Campbell,
  • Olivia Villers,
  • Mark W. Bondi and ,
  • Ben Gouaux,
  • David P. Salmon,
  • Douglas Galasko,
  • Virawudh Soontornniyomkij,
  • Ronald J. Ellis and
  • David J. Moore
  • + 5 authors+ 0 author

4 June 2023

We determined the prevalence of Alzheimer’s disease (AD) pathological hallmarks, amyloid-β and phosphorylated-Tau, in autopsied brains of 49 people with HIV (PWH) (ages: 50–68; mean age = 57.0) from the National NeuroAIDS Tissue Cons...

(This article belongs to the Special Issue HIV, Aging and Comorbidity)
  • Article
  • Open Access
12 Citations
3,662 Views
18 Pages

Effects of Alzheimer-Like Pathology on Homocysteine and Homocysteic Acid Levels—An Exploratory In Vivo Kinetic Study

  • Hendrik Nieraad,
  • Natasja de Bruin,
  • Olga Arne,
  • Martine C. J. Hofmann and ,
  • Robert Gurke,
  • Dominik Schmidt,
  • Marcel Ritter,
  • Michael J. Parnham and
  • Gerd Geisslinger
  • + 4 authors+ 0 author

Hyperhomocysteinemia has been suggested potentially to contribute to a variety of pathologies, such as Alzheimer’s disease (AD). While the impact of hyperhomocysteinemia on AD has been investigated extensively, there are scarce data on the effe...

(This article belongs to the Special Issue Amyloids, Prions and Related Phenomena)
  • Review
  • Open Access
111 Citations
15,706 Views
11 Pages

Alzheimer’s disease (AD) is the major causative disease of dementia and is characterized pathologically by the accumulation of senile plaques (SPs) and neurofibrillary tangles (NFTs) in the brain. Although genetic studies show that β-amyloid protein...

(This article belongs to the Special Issue Molecular Research on Obesity and Diabetes)
  • Article
  • Open Access
27 Citations
6,141 Views
11 Pages

Hippocampal LMNA Gene Expression is Increased in Late-Stage Alzheimer’s Disease

  • Iván Méndez-López,
  • Idoia Blanco-Luquin,
  • Javier Sánchez-Ruiz de Gordoa,
  • Amaya Urdánoz-Casado and ,
  • Miren Roldán,
  • Blanca Acha,
  • Carmen Echavarri,
  • Victoria Zelaya,
  • Ivonne Jericó and
  • Maite Mendioroz
  • + 5 authors+ 0 author

18 February 2019

Lamins are fibrillary proteins that are crucial in maintaining nuclear shape and function. Recently, B-type lamin dysfunction has been linked to tauopathies. However, the role of A-type lamin in neurodegeneration is still obscure. Here, we examined A...

(This article belongs to the Special Issue Genomics of Brain Disorders)
  • Article
  • Open Access
13 Citations
4,064 Views
11 Pages

19 November 2021

Previous studies have demonstrated that the accumulation of amyloid-β (Aβ) pathologies has distinctive stage-specific effects on the structural and functional brain networks along the Alzheimer’s disease (AD) continuum. A more compreh...

(This article belongs to the Topic Mechanisms and Treatments of Neurodegenerative Diseases)
  • Article
  • Open Access
12 Citations
4,040 Views
18 Pages

Oleocanthal Ameliorates Metabolic and Behavioral Phenotypes in a Mouse Model of Alzheimer’s Disease

  • Euitaek Yang,
  • Junwei Wang,
  • Lauren N. Woodie,
  • Michael W. Greene and
  • Amal Kaddoumi

23 July 2023

Aging is a major risk factor for Alzheimer’s disease (AD). AD mouse models are frequently used to assess pathology, behavior, and memory in AD research. While the pathological characteristics of AD are well established, our understanding of the...

  • Article
  • Open Access
19 Citations
5,197 Views
27 Pages

Feeding High-Fat Diet Accelerates Development of Peripheral and Central Insulin Resistance and Inflammation and Worsens AD-like Pathology in APP/PS1 Mice

  • Anna Mengr,
  • Veronika Strnadová,
  • Štěpán Strnad,
  • Vladimír Vrkoslav and ,
  • Helena Pelantová,
  • Marek Kuzma,
  • Thomas Comptdaer,
  • Blanka Železná,
  • Jaroslav Kuneš and
  • Lenka Maletínská
  • + 7 authors+ 2 authors

23 August 2023

Alzheimer’s disease (AD) is a progressive brain disorder characterized by extracellular amyloid-β (Aβ) plaques, intracellular neurofibrillary tangles formed by hyperphosphorylated Tau protein and neuroinflammation. Previous research h...

(This article belongs to the Special Issue Nutrition and Glucose Homeostasis—2nd Edition)
  • Article
  • Open Access
66 Citations
11,029 Views
27 Pages

Branched-Chain Amino Acids Are Linked with Alzheimer’s Disease-Related Pathology and Cognitive Deficits

  • Md Abu Bakkar Siddik,
  • Caitlyn A. Mullins,
  • Alyssa Kramer,
  • Harsh Shah and ,
  • Ritchel B. Gannaban,
  • Masoud Zabet-Moghaddam,
  • Ryan M. Huebinger,
  • Vijay K. Hegde,
  • Sheba M. J. MohanKumar and
  • Andrew C. Shin
  • + 6 authors+ 1 author

7 November 2022

Alzheimer’s disease (AD) is an irreversible neurodegenerative disorder with a complex pathophysiology. Type 2 diabetes (T2D) is a strong risk factor for AD that shares similar abnormal features including metabolic dysregulation and brain pathol...

(This article belongs to the Section Cellular Neuroscience)
  • Article
  • Open Access
38 Citations
4,769 Views
15 Pages

Alzheimer’s disease (AD) is the most common type of dementia and is currently incurable, and mitogen-activated protein kinase (MAPK) p38 is implicated in the pathogenesis of AD. p38 MAPK inhibition is considered a promising strategy against AD,...

(This article belongs to the Special Issue Dietary Antioxidants for Modulating the Aging Processes)
  • Article
  • Open Access
36 Citations
5,836 Views
20 Pages

Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD

  • Kyung-Min Han,
  • Ri Jin Kang,
  • Hyongjun Jeon,
  • Hyun-ju Lee and ,
  • Ji-Soo Lee,
  • HyunHee Park,
  • Seong Gak Jeon,
  • Kyoungho Suk,
  • Jinsoo Seo and
  • Hyang-Sook Hoe
  • + 5 authors+ 0 author

9 July 2020

The oral multi-target kinase inhibitor regorafenib, which targets the oncogenic receptor tyrosine kinase (RTK), is an effective therapeutic for patients with advanced gastrointestinal stromal tumors or metastatic colorectal cancer. However, whether r...

(This article belongs to the Collection Targeting Signal Transduction Pathways and Non-coding RNAs as Potential Therapy in Cancer and Aging)
  • Review
  • Open Access
20 Citations
4,638 Views
20 Pages

Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor

  • Mackayla L. Nelson,
  • Julia A. Pfeifer,
  • Jordan P. Hickey,
  • Andrila E. Collins and
  • Bettina E. Kalisch

24 July 2023

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that debilitates over 55 million individuals worldwide. Currently, treatments manage and alleviate its symptoms; however, there is still a need to find a therapy that prevents...

(This article belongs to the Special Issue Roles and Functions of Neurotrophins and Their Receptors in the Brain)
  • Article
  • Open Access
39 Citations
5,683 Views
13 Pages

11 November 2019

Alzheimer’s disease (AD) is the commonest type of late-life dementia and damages the cerebral cortex, a vulnerable brain region implicated in memory, emotion, cognition, and decision-making behavior. AD is characterized by progressive neuronal...

(This article belongs to the Special Issue Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules)
  • Review
  • Open Access
32 Citations
11,415 Views
48 Pages

Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer’s Disease

  • Juan Antonio Garcia-Leon,
  • Laura Caceres-Palomo,
  • Elisabeth Sanchez-Mejias,
  • Marina Mejias-Ortega and ,
  • Cristina Nuñez-Diaz,
  • Juan Jose Fernandez-Valenzuela,
  • Raquel Sanchez-Varo,
  • Jose Carlos Davila,
  • Javier Vitorica and
  • Antonia Gutierrez
  • + 5 authors+ 0 author

18 September 2020

Extracellular amyloid-beta deposition and intraneuronal Tau-laden neurofibrillary tangles are prime features of Alzheimer’s disease (AD). The pathology of AD is very complex and still not fully understood, since different neural cell types are...

(This article belongs to the Special Issue hiPSC-Derived Cells as Models for Drug Discovery)
  • Article
  • Open Access
47 Citations
8,416 Views
23 Pages

Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic and Pathological Abnormalities in a Mouse Model of Alzheimer’s Disease

  • Enrique Armijo,
  • George Edwards,
  • Andrea Flores,
  • Jorge Vera and ,
  • Mohammad Shahnawaz,
  • Fabio Moda,
  • Cesar Gonzalez,
  • Magdalena Sanhueza and
  • Claudio Soto
  • + 4 authors+ 0 author

16 July 2021

Alzheimer’s disease (AD) is the most common type of dementia in the elderly population. The disease is characterized by progressive memory loss, cerebral atrophy, extensive neuronal loss, synaptic alterations, brain inflammation, extracellular accumu...

(This article belongs to the Special Issue iPS Cells (iPSCs) for Modelling and Treatment of Human Diseases)
  • Article
  • Open Access
4 Citations
4,331 Views
11 Pages

Amelioration of Experimental Autoimmune Encephalomyelitis in Alzheimer’s Disease Mouse Models: A Potential Role for Aβ

  • Changjie Shi,
  • Jiaxue Cha,
  • Junyuan Gong,
  • Shaodeng Wang and ,
  • Peng Zeng,
  • Junjiang Lian,
  • Bowen Zhang,
  • Qiuhong Hua,
  • Jie Lv and
  • Ru Zhang
  • + 7 authors+ 2 authors

16 March 2022

Emerging data have highlighted the coexistence of multiple sclerosis (MS) and Alzheimer’s disease (AD), both of which are common central nervous system degenerative diseases with a heavy burden on patients, their families, and society. However,...

(This article belongs to the Special Issue Cellular and Molecular Mechanisms of Neurodegenerative Diseases)
  • Review
  • Open Access
11 Citations
3,898 Views
18 Pages

The Role of Insulin-like Growth Factor I in Mechanisms of Resilience and Vulnerability to Sporadic Alzheimer’s Disease

  • Jonathan A. Zegarra-Valdivia,
  • Jaime Pignatelli,
  • Angel Nuñez and
  • Ignacio Torres Aleman

17 November 2023

Despite decades of intense research, disease-modifying therapeutic approaches for Alzheimer’s disease (AD) are still very much needed. Apart from the extensively analyzed tau and amyloid pathological cascades, two promising avenues of research...

(This article belongs to the Special Issue Recent Advances in Alzheimer’s Disease)
  • Review
  • Open Access
104 Citations
10,483 Views
26 Pages

Contributions of DNA Damage to Alzheimer’s Disease

  • Xiaozeng Lin,
  • Anil Kapoor,
  • Yan Gu,
  • Mathilda Jing Chow and ,
  • Jingyi Peng,
  • Kuncheng Zhao and
  • Damu Tang
  • + 2 authors+ 0 author

28 February 2020

Alzheimer’s disease (AD) is the most common type of neurodegenerative disease. Its typical pathology consists of extracellular amyloid-β (Aβ) plaques and intracellular tau neurofibrillary tangles. Mutations in the APP, PSEN1, and PSEN...

(This article belongs to the Section Molecular Neurobiology)
  • Review
  • Open Access
60 Citations
11,582 Views
39 Pages

8 September 2020

Alzheimer’s disease (AD) is the most common type of dementia, affecting more than 5 million Americans, with steadily increasing mortality and incredible socio-economic burden. Not only have therapeutic efforts so far failed to reach significant...

(This article belongs to the Special Issue Novel Biomarkers in Alzheimer’s Disease)
  • Article
  • Open Access
37 Citations
5,705 Views
12 Pages

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia worldwide, with no cure. There is growing interest in mitogen-activated protein kinases (MAPKs) as possible pathogenesis-related therapeutic ta...

(This article belongs to the Special Issue Antioxidants in Age-Related Diseases and Anti-Aging Strategies)
  • Review
  • Open Access
47 Citations
11,742 Views
13 Pages

Towards a Consensus on Alzheimer’s Disease Comorbidity?

  • Iska Avitan,
  • Yudit Halperin,
  • Trishna Saha,
  • Naamah Bloch and ,
  • Dana Atrahimovich,
  • Baruh Polis,
  • Abraham O. Samson and
  • Ori Braitbard
  • + 3 authors+ 0 author

24 September 2021

Alzheimer’s disease (AD) is often comorbid with other pathologies. First, we review shortly the diseases most associated with AD in the clinic. Then we query PubMed citations for the co-occurrence of AD with other diseases, using a list of 400 common...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
1,580 Views
20 Pages

PICALM Genetic Variant Alters mRNA Expression Without Affecting Protein Levels or Tau Spreading in Alzheimer’s Disease

  • Kunie Ando,
  • Lidia Lopez-Gutierrez,
  • Salwa Mansour,
  • Zehra Yilmaz and ,
  • Luce Dauphinot,
  • Jan Verheijen,
  • Gaëlle Fontaine,
  • Carolina Quintanilla-Sánchez,
  • Emmanuel Aydin and
  • Karelle Leroy
  • + 12 authors+ 7 authors

26 January 2026

Phosphatidylinositol-binding clathrin assembly protein (PICALM) is a clathrin adaptor essential for clathrin-mediated endocytosis. Genome-wide association studies (GWAS) have consistently identified PICALM as one of the most significant genetic susce...

  • Article
  • Open Access
13 Citations
6,021 Views
27 Pages

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease

  • Micha M. M. Wilhelmus,
  • Elisa Tonoli,
  • Clare Coveney,
  • David J. Boocock and ,
  • Cornelis A. M. Jongenelen,
  • John J. P. Brevé,
  • Elisabetta A. M. Verderio and
  • Benjamin Drukarch
  • + 3 authors+ 0 author

24 January 2022

Amyloid-beta (Aβ) deposition in the brain is closely linked with the development of Alzheimer’s disease (AD). Unfortunately, therapies specifically targeting Aβ deposition have failed to reach their primary clinical endpoints, emphasi...

(This article belongs to the Special Issue Function of Transglutaminases in Adhesion Dynamics, Differentiation, and Cell Survival)
  • Review
  • Open Access
48 Citations
13,365 Views
26 Pages

Alcohol as a Modifiable Risk Factor for Alzheimer’s Disease—Evidence from Experimental Studies

  • Devaraj V. Chandrashekar,
  • Ross A. Steinberg,
  • Derick Han and
  • Rachita K. Sumbria

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by cognitive impairment and memory loss. Epidemiological evidence suggests that heavy alcohol consumption aggravates AD pathology, whereas low alcohol intake may...

(This article belongs to the Special Issue New Trends in Alzheimer's Disease Research: From Molecular Mechanisms to Therapeutics)
  • Review
  • Open Access
40 Citations
8,454 Views
15 Pages

3 November 2021

The majority of neurodegenerative diseases are pathologically associated with protein misfolding and aggregation. Alzheimer’s disease (AD) is a type of dementia that slowly affects memory and cognitive function, and is characterized by the aggregatio...

(This article belongs to the Special Issue Protein Folding, Aggregation, and Cell Death)
  • Review
  • Open Access
10 Citations
4,241 Views
17 Pages

17 October 2022

Neurons interact with astrocytes, microglia, and vascular cells. These interactions become unbalanced in disease states, resulting in damage to neurons and synapses, and contributing to cognitive impairment. Importantly, synaptic loss and synaptic dy...

(This article belongs to the Special Issue Cellular and Molecular Mechanisms of Neurodegenerative and Neurological Diseases)
  • Review
  • Open Access
32 Citations
5,803 Views
13 Pages

The P2X7 Receptor, a Multifaceted Receptor in Alzheimer’s Disease

  • Kaitryn E. Ronning,
  • Paul-Alexandre Déchelle-Marquet,
  • Yueshen Che,
  • Xavier Guillonneau and ,
  • Florian Sennlaub and
  • Cécile Delarasse
  • + 1 author+ 0 author

Alzheimer’s disease (AD) is a progressive neurodegenerative disease characterized by impaired episodic memory and two pathological lesions: amyloid plaques and neurofibrillary tangles. In AD, damaged neurons and the accumulation of amyloid &bet...

(This article belongs to the Special Issue The Role of P2X7 Receptor in Human Health and Diseases)
  • Article
  • Open Access
17 Citations
5,802 Views
20 Pages

Alzheimer’s disease (AD) is one of the leading causes of death worldwide, with no definitive diagnosis or known cure. The aggregation of Tau protein into neurofibrillary tangles (NFTs), which contain straight filaments (SFs) and paired helical...

(This article belongs to the Collection Feature Papers in Materials Science)
  • Article
  • Open Access
17 Citations
4,700 Views
12 Pages

Evaluation of Plant Ceramide Species-Induced Exosome Release from Neuronal Cells and Exosome Loading Using Deuterium Chemistry

  • Yuta Murai,
  • Takumi Honda,
  • Kohei Yuyama,
  • Daisuke Mikami and ,
  • Koichi Eguchi,
  • Yuichi Ukawa,
  • Seigo Usuki,
  • Yasuyuki Igarashi and
  • Kenji Monde
  • + 4 authors+ 0 author

15 September 2022

The extracellular accumulation of aggregated amyloid-β (Aβ) in the brain leads to the early pathology of Alzheimer’s disease (AD). The administration of exogenous plant-type ceramides into AD model mice can promote the release of neur...

(This article belongs to the Special Issue Exosomes)
  • Review
  • Open Access
17 Citations
7,579 Views
85 Pages

30 October 2024

Background/Objectives. Obesity, type 2 diabetes (T2D), and Alzheimer’s disease (AD) are pathologies that affect millions of people worldwide. They have no effective therapy and are difficult to prevent and control when they develop. It has been...

(This article belongs to the Section Molecular and Cellular Neuroscience)
  • Review
  • Open Access
9 Citations
4,921 Views
19 Pages

Alzheimer’s disease (AD) is the most common type of dementia, contributing to 60–80% of cases. It is a neurodegenerative disease that usually starts symptomless in the first two to three decades and then propagates into a long-term, irreversible dise...

(This article belongs to the Section Cell Biology and Pathology)
  • Review
  • Open Access
45 Citations
5,901 Views
14 Pages

miRNAs as Therapeutic Tools in Alzheimer’s Disease

  • Chang Youn Lee,
  • In Soo Ryu,
  • Jin-Hyeob Ryu and
  • Hyun-Jeong Cho

1 December 2021

Alzheimer’s disease (AD), an age-dependent, progressive neurodegenerative disorder, is the most common type of dementia, accounting for 50–70% of all dementia cases. Due to the increasing incidence and corresponding socioeconomic burden o...

(This article belongs to the Special Issue Alzheimer's disease: From Molecular Basis to Therapy)
  • Article
  • Open Access
9 Citations
3,676 Views
25 Pages

30 January 2024

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that is characterized by amyloid-beta (Aβ) plaques and tau neurofibrillary tangles (NFT). Modelling aspects of AD is challenging due to its complex multifactorial etiolog...

(This article belongs to the Special Issue Role of Amyloid Protein in Neurological Diseases)
  • Review
  • Open Access
16 Citations
4,760 Views
27 Pages

Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer’s Disease

  • Amy Woodfield,
  • Tatiana Gonzales,
  • Erik Helmerhorst,
  • Simon Laws and ,
  • Philip Newsholme,
  • Tenielle Porter and
  • Giuseppe Verdile
  • + 2 authors+ 0 author

13 December 2022

Alzheimer’s disease (AD) and type 2 diabetes (T2D) are chronic diseases that share several pathological mechanisms, including insulin resistance and impaired insulin signalling. Their shared features have prompted the evaluation of the drugs us...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
58 Citations
7,929 Views
18 Pages

Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer’s Disease

  • Sujin Kim,
  • Hyunju Chung,
  • Han Ngoc Mai,
  • Yunkwon Nam and ,
  • Soo Jung Shin,
  • Yong Ho Park,
  • Mi Joo Chung,
  • Jong Kil Lee,
  • Hak Young Rhee and
  • Weon Kuu Chung
  • + 10 authors+ 5 authors

Alzheimer’s disease (AD) is the most common type of dementia. AD involves major pathologies such as amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain. During the progression of AD, microglia can be polarized from anti-in...

(This article belongs to the Collection Feature Papers in Molecular Biophysics)
  • Article
  • Open Access
4 Citations
5,584 Views
12 Pages

Apraxia Patterns for the Differentiation between Alzheimer’s Disease and Frontotemporal Dementia Variants

  • Georgios Papadopoulos,
  • Dimitrios Parissis,
  • Anna Gotzamani-Psarrakou and
  • Panagiotis Ioannidis

6 March 2024

Background and Objectives: Despite the increasing use of biomarkers, differentiation between Alzheimer’s disease (AD), behavioral variant Frontotemporal Dementia (bvFTD), and Primary Progressive Aphasia (PPA) remains a challenge. Apraxia is a s...

(This article belongs to the Section Neurology)
  • Article
  • Open Access
16 Citations
4,559 Views
14 Pages

The activation of the microglia plays an important role in the neuroinflammation induced by different stimulations associated with Alzheimer’s disease (AD). Different stimulations, such as pathogen-associated molecular patterns (PAMPs), damage-...

(This article belongs to the Special Issue Therapeutic Agents for Neurodegenerative Disorders)
  • Article
  • Open Access
11 Citations
3,810 Views
18 Pages

Glia Not Neurons: Uncovering Brain Dysmaturation in a Rat Model of Alzheimer’s Disease

  • Ekaterina A. Rudnitskaya,
  • Tatiana A. Kozlova,
  • Alena O. Burnyasheva,
  • Natalia A. Stefanova and
  • Nataliya G. Kolosova

Sporadic Alzheimer’s disease (AD) is a severe disorder of unknown etiology with no definite time frame of onset. Recent studies suggest that middle age is a critical period for the relevant pathological processes of AD. Nonetheless, sufficient data h...

(This article belongs to the Special Issue Alzheimer's Disease—115 Years after Its Discovery)
  • Article
  • Open Access
6 Citations
3,835 Views
16 Pages

21 August 2023

Alzheimer’s disease (AD) is one representative dementia characterized by the accumulation of amyloid beta (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain, resulting in cognitive decline and memory loss. AD is associated with n...

(This article belongs to the Collection Feature Papers in Molecular Neurobiology)
  • Review
  • Open Access
11 Citations
7,901 Views
23 Pages

26 August 2018

One of the most commonly known chronic neurodegenerative disorders, Alzheimer’s disease (AD), manifests the common type of dementia in 60–80% of cases. From a clinical standpoint, a patent cognitive decline and a severe change in personal...

  • Article
  • Open Access
4 Citations
3,510 Views
11 Pages

Alzheimer’s Disease Related Biomarkers Were Associated with Amnestic Cognitive Impairment in Parkinson’s Disease: A Cross-Sectional Cohort Study

  • Xiaofan Xue,
  • Shanshan Mei,
  • Anqi Huang,
  • Zhiyue Wu and ,
  • Jingrong Zeng,
  • Haixia Song,
  • Jing An,
  • Lijuan Zhang,
  • Guozhen Liu and
  • Piu Chan
  • + 9 authors+ 4 authors

Background: Cognitive impairment is common in patients with Parkinson’s disease (PD) and occurs through multiple mechanisms, including Alzheimer’s disease (AD) pathology and the involvement of α-synucleinopathies. We aimed to invest...

(This article belongs to the Special Issue Advances in Invasive and Non-invasive Brain Stimulation in Movement Disorders)
  • Article
  • Open Access
4 Citations
4,816 Views
19 Pages

Co-Aggregation of Syndecan-3 with β-Amyloid Aggravates Neuroinflammation and Cognitive Impairment in 5×FAD Mice

  • Fan Ye,
  • Mingfeng Li,
  • Min Liu,
  • Xinghan Wu and ,
  • Fan Tian,
  • Yanju Gong,
  • Yan Cao,
  • Jingtai Zhang,
  • Xueling Zhang and
  • Ling Zhang
  • + 6 authors+ 1 author

Abnormal deposition of β-amyloid (Aβ) is a core pathological feature of Alzheimer’s disease (AD). Syndecan-3 (SDC3), a type I transmembrane heparan sulfate proteoglycan (HSPG), is abnormally overexpressed in the brains of AD patients...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
555 Views
27 Pages

Alzheimer’s Disease Leads to Chronic Pathological Changes and Inflammasome Signaling in an Animal Model of Traumatic Brain Injury

  • Erika d. l. R. M. Cabrera Ranaldi,
  • Nathan H. Johnson,
  • Andrew P. Sawaya,
  • Jhianyn R. Herrera and ,
  • Nadine Ahmed Kerr,
  • Helen M. Bramlett,
  • Robert W. Keane,
  • W. Dalton Dietrich and
  • Juan Pablo de Rivero Vaccari
  • + 4 authors+ 0 author

14 September 2026

Traumatic brain injury (TBI) is a significant public health concern, often resulting in long-term impairments. TBI is also a known risk factor for Alzheimer’s disease (AD), with both conditions sharing features such as inflammasome dysregulatio...

(This article belongs to the Special Issue Role of Inflammasomes in Neurological Disorders)

of 9